AAAAAA

   
Results: 1-7 |
Results: 7
ASSOCIATION OF RED-BLOOD METHYLFOLATE BUT NOT PLASMA FOLATE WITH C677T MTHFR POLYMORPHISM IN VENOUS THROMBOEMBOLIC DISEASE
Authors: QUERE I WUTSCHERT R ZITTOUN J BELLET H REBER G GRIS JC JANBON C SCHVED JF DEMOERLOOSE P
Citation: I. Quere et al., ASSOCIATION OF RED-BLOOD METHYLFOLATE BUT NOT PLASMA FOLATE WITH C677T MTHFR POLYMORPHISM IN VENOUS THROMBOEMBOLIC DISEASE, Thrombosis and haemostasis, 80(4), 1998, pp. 707-709
SUPERFICIAL VEIN-THROMBOSIS OF LOWER-LIMBS - INFLUENCE OF FACTOR-V-LEIDEN, FACTOR-II G20210A AND OVERWEIGHT
Authors: DEMOERLOOSE P WUTSCHERT R HEINZMANN M PERNEGER T REBER G BOUNAMEAUX H
Citation: P. Demoerloose et al., SUPERFICIAL VEIN-THROMBOSIS OF LOWER-LIMBS - INFLUENCE OF FACTOR-V-LEIDEN, FACTOR-II G20210A AND OVERWEIGHT, Thrombosis and haemostasis, 80(2), 1998, pp. 239-241
PHARMACOTHERAPEUTIC STRATEGIES IN PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Authors: BOUNAMEAUX H WUTSCHERT R
Citation: H. Bounameaux et R. Wutschert, PHARMACOTHERAPEUTIC STRATEGIES IN PERIPHERAL ARTERIAL OCCLUSIVE DISEASE, Drugs, 56, 1998, pp. 17-23
EFFECTS OF INTERMITTENT PNEUMATIC COMPRESSION ON VENOUS HEMODYNAMICS AND FIBRINOLYTIC-ACTIVITY
Authors: CHRISTEN Y WUTSCHERT R WEIMER D DEMOERLOOSE P KRUITHOF EKO BOUNAMEAUX H
Citation: Y. Christen et al., EFFECTS OF INTERMITTENT PNEUMATIC COMPRESSION ON VENOUS HEMODYNAMICS AND FIBRINOLYTIC-ACTIVITY, Blood coagulation & fibrinolysis, 8(3), 1997, pp. 185-190
AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL
Authors: BOUNAMEAUX H EHRINGER H HULTING J RASCHE H RAPOLD HJ ZULTAK M RAMES A BASLE CH TENCATE JW SCHNEIDER PA GENEVA CH SCHMITT HE SLOSMAN DO PERRIER A SPANNAGL H GSCHWANDTNER ME BANYAI M KOPPENSTEINER R MINAR E STUMPFLEN A HAUMER M VERHAEGHE R VERMYLEN J WAUTRECHT JC TAGHIZADEH K BRUHN HD LINS M ZURBORN KH SCHWARZENBERG H SCHAUER J SCHEEL H RUHLMANN C VOIGT H WAGNER T SIEMENS HJ SCHWIEDER G HEENE D DEMPFLE CE HARENBERG J PFITZNER S BROCKHAUS W SCHUSTER O WEISSHAAR K SEBIGER R HOFMANN B ANDERS O KRAMMER B PLATH F LESTIN H BAUMANN N EHRERTREICH U MULLERESCH G RUPRECHT B WEDEEN G LARFARS G WALLVIK J BJUHR O DIDIER D DESMARAIS S WUTSCHERT R DEMOERLOOSE P CHRISTEN Y BERNARD C KUPKA S KIRISITS A JANSSEN M VERWEIJ G KRAAJ CJ SITTNER WD HANKA U MAIER A JOHANSSON AS JOHANSSON E OLESEN M BREIER E WITTKE B GOGGIN T STEPHENSON C TURKISH M WILLIAMS L DUTREIX C GAUTSCH A NONN D WARD R LOWE P LAD K GREEN D GRAVEL A
Citation: H. Bounameaux et al., AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL, Thrombosis and haemostasis, 78(3), 1997, pp. 997-1002
DETERMINATION OF AMPUTATION LEVEL IN ISCHEMIC LIMBS - REAPPRAISAL OF THE MEASUREMENT OF TCPO2
Authors: WUTSCHERT R BOUNAMEAUX H
Citation: R. Wutschert et H. Bounameaux, DETERMINATION OF AMPUTATION LEVEL IN ISCHEMIC LIMBS - REAPPRAISAL OF THE MEASUREMENT OF TCPO2, Diabetes care, 20(8), 1997, pp. 1315-1318
ANTITHROMBOTICS UTILIZATION IN PERIPHERAL ARTERIAL-DISEASE
Authors: WUTSCHERT R BOUNAMEAUX H
Citation: R. Wutschert et H. Bounameaux, ANTITHROMBOTICS UTILIZATION IN PERIPHERAL ARTERIAL-DISEASE, Archives des maladies du coeur et des vaisseaux, 89(11), 1996, pp. 1551-1555
Risultati: 1-7 |